Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
Shandong Xinhua Pharmaceutical (000756)
- 14.61
- -0.15-1.02%
Market Closed Apr 17 15:00 CST
10.18BMarket Cap35.12P/E (TTM)
14.75High14.53Low43.68KlotVolume14.67Open14.76Prev Close63.76MTurnover0.88%Turnover Ratio35.12P/E (Static)696.68MShares18.7052wk High1.94P/B7.29BFloat Cap13.4152wk Low16.24Limit Up498.90MShs Float48.13Historical High13.28Limit Down1.49%Range %0.29Historical Low0.25Dividend TTM14.60Avg Price29.20KlotAsk1.71%Div Yield TTM100Lot Size13.88KlotBid
Shandong Xinhua Pharmaceutical (000756) Income Statement
All
YOY
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 3.41%8.75B | 0.42%6.76B | -1.98%4.64B | -1.81%2.43B | 4.51%8.47B | 3.64%6.73B | 1.29%4.73B | -6.25%2.47B | 7.97%8.1B | 19.15%6.5B |
| Operating revenue | 3.41%8.75B | 0.42%6.76B | -1.98%4.64B | -1.81%2.43B | 4.51%8.47B | 3.64%6.73B | 1.29%4.73B | -6.25%2.47B | 7.97%8.1B | 19.15%6.5B |
| Other operating revenue | -13.16%123.7M | ---- | -20.83%60.08M | ---- | -1.62%142.44M | ---- | -1.58%75.88M | ---- | -30.33%144.78M | ---- |
| Total operating cost | 5.67%8.39B | 1.53%6.43B | -1.60%4.34B | -1.24%2.3B | 5.44%7.94B | 4.93%6.34B | 2.38%4.41B | -5.33%2.33B | 7.27%7.53B | 18.00%6.04B |
| Operating cost | 10.67%7.11B | 6.10%5.47B | 4.55%3.71B | 9.94%1.97B | 12.53%6.42B | 11.82%5.15B | 8.13%3.55B | -0.86%1.8B | 4.45%5.71B | 14.21%4.61B |
| Operating tax surcharges | -4.84%65.1M | -3.23%49.99M | -7.31%34.2M | -3.02%17.88M | -25.78%68.41M | -34.27%51.66M | -38.98%36.9M | -56.17%18.43M | 41.14%92.18M | 61.26%78.6M |
| Operating expense | -41.67%341.08M | -46.41%270.22M | -57.23%172.61M | -65.66%99.95M | -25.05%584.74M | -21.64%504.22M | -17.14%403.57M | -17.52%291.06M | 18.51%780.17M | 42.03%643.45M |
| Administration expense | 4.71%457.66M | 11.74%326.74M | 18.79%215.1M | 19.28%94.04M | -14.94%437.07M | -18.59%292.41M | -26.49%181.07M | -37.52%78.84M | 13.30%513.82M | 16.68%359.16M |
| Financial expense | 184.77%34.57M | 105.29%20.97M | 510.54%9.88M | 36.57%4.04M | -25.75%12.14M | 9.12%10.21M | 20.56%1.62M | -81.02%2.95M | -48.93%16.35M | -40.86%9.36M |
| -Interest expense (Financial expense) | 6.77%42.43M | 2.30%28.76M | 20.04%21.45M | 18.75%10.95M | -3.42%39.74M | -11.33%28.12M | -16.85%17.87M | -21.92%9.22M | -17.22%41.15M | -14.42%31.71M |
| -Interest Income (Financial expense) | 30.92%-7.69M | 46.82%-4.43M | 0.75%-4.55M | 16.35%-2.41M | 9.55%-11.13M | 14.27%-8.32M | 31.95%-4.58M | 22.18%-2.88M | -17.57%-12.3M | -50.52%-9.71M |
| Research and development | -7.64%381.62M | -8.13%300.11M | -16.73%202.43M | -22.63%109.79M | -1.44%413.18M | -4.28%326.67M | 3.22%243.11M | 26.57%141.91M | 21.29%419.24M | 32.03%341.28M |
| Credit Impairment Loss | 43.44%-5.35M | -11.92%-9.04M | -11.50%-9.14M | 42.86%100K | 8.08%-9.46M | -161.42%-8.07M | -135.60%-8.19M | 13,900.00%70K | -102.82%-10.29M | -51.93%-3.09M |
| Asset Impairment Loss | 8.18%-47.39M | -4.09%-50.29M | -4.09%-50.29M | ---- | 25.50%-51.61M | -8.96%-48.31M | -8.96%-48.31M | ---- | -59.17%-69.28M | -51.08%-44.34M |
| Other net revenue | -106.27%-524.44K | -1,498.17%-16.69M | -189.98%-31.08M | -46.21%13.33M | 123.67%8.37M | 110.46%1.19M | 59.65%-10.72M | 295.08%24.79M | -509.37%-35.36M | -510.35%-11.41M |
| Invest income | -21.06%7.76M | -27.34%6.1M | -38.22%5.88M | -163.95%-760.24K | 2.64%9.84M | -13.31%8.4M | 14.85%9.52M | 1,423.42%1.19M | 14.57%9.58M | -5.91%9.69M |
| -Including: Investment income associates | -440.65%-539.32K | -521.61%-916.47K | -185.44%-1.14M | -163.95%-760.24K | -88.83%158.32K | -85.73%217.37K | 1,006.56%1.33M | 1,423.42%1.19M | 217.01%1.42M | -35.98%1.52M |
| Asset deal income | 40.23%1.99M | 52.59%1.83M | 37.97%1.71M | 108.36%1.76M | -83.75%1.42M | -85.49%1.2M | -2.66%1.24M | 60.97%845.11K | 57.66%8.73M | 308.47%8.28M |
| Other revenue | -27.02%42.47M | -27.68%34.7M | -40.76%20.75M | -46.07%12.23M | 124.65%58.19M | 165.77%47.98M | 199.54%35.03M | 300.03%22.68M | -10.36%25.9M | -17.33%18.05M |
| Operating profit | -31.89%363.98M | -21.71%311.8M | -14.09%264.25M | -16.06%143.17M | -0.04%534.37M | -10.88%398.27M | -7.90%307.57M | -8.20%170.56M | 12.14%534.58M | 32.18%446.87M |
| Add:Non operating Income | -36.15%5.42M | 304.13%2.66M | 787.24%2.9M | 67.69%325.01K | 53.17%8.48M | -84.28%659.43K | -48.33%326.56K | -46.13%193.82K | 195.38%5.54M | 215.97%4.19M |
| Less:Non operating expense | 13.97%10.48M | 40.88%8.47M | -20.19%3.62M | -59.23%806.9K | 23.75%9.2M | 31.07%6.01M | 71.53%4.53M | 59.81%1.98M | 9.21%7.43M | -4.44%4.59M |
| Total profit | -32.74%358.92M | -22.12%306M | -13.13%263.53M | -15.45%142.69M | 0.18%533.65M | -12.00%392.92M | -8.61%303.36M | -8.73%168.77M | 12.91%532.69M | 33.43%446.48M |
| Less:Income tax cost | 12.09%52.61M | 4.32%39.09M | 5.76%32.36M | 15.05%27.05M | 76.60%46.94M | -18.88%37.47M | -45.62%30.6M | -23.95%23.51M | -41.80%26.58M | 47.04%46.19M |
| Net profit | -37.07%306.3M | -24.91%266.91M | -15.25%231.17M | -20.39%115.64M | -3.83%486.71M | -11.20%355.45M | -1.06%272.77M | -5.68%145.26M | 18.77%506.11M | 32.02%400.29M |
| Net profit from continuing operation | -37.07%306.3M | -24.91%266.91M | -15.25%231.17M | -20.39%115.64M | -3.83%486.71M | -11.20%355.45M | -1.06%272.77M | -5.68%145.26M | 18.77%506.11M | 32.02%400.29M |
| Less:Minority Profit | -1.65%16.42M | -5.99%10.69M | 0.68%7.41M | 4.84%3.55M | 73.96%16.69M | 36.63%11.37M | 25.35%7.36M | 40.64%3.38M | -36.23%9.59M | -14.68%8.32M |
| Net profit of parent company owners | -38.32%289.89M | -25.53%256.22M | -15.69%223.76M | -20.99%112.1M | -5.33%470.02M | -12.22%344.08M | -1.63%265.4M | -6.41%141.88M | 20.79%496.51M | 33.58%391.97M |
| Earning per share | ||||||||||
| Basic earning per share | -39.13%0.42 | -26.00%0.37 | -17.95%0.32 | -28.57%0.15 | -6.76%0.69 | -13.79%0.5 | -2.50%0.39 | -8.70%0.21 | 19.35%0.74 | 28.89%0.58 |
| Diluted earning per share | -38.24%0.42 | -26.00%0.37 | -15.79%0.32 | -28.57%0.15 | -5.56%0.68 | -12.28%0.5 | -2.56%0.38 | -4.55%0.21 | 18.03%0.72 | 29.55%0.57 |
| Other composite income | -53.73%26.02M | -106.78%-5.08M | -46.80%14.54M | -1,405.62%-10.65M | 3,139.17%56.23M | 208.26%74.96M | 96.98%27.33M | -89.42%815.33K | 113.41%1.74M | 209.72%24.32M |
| Other composite income of parent company owners | -52.91%26.36M | -106.45%-4.85M | -46.91%14.65M | -1,409.56%-10.57M | 3,653.81%55.98M | 215.13%75.22M | 106.79%27.6M | -89.77%807.37K | 110.56%1.49M | 201.01%23.87M |
| Other composite income of minority owners | -234.33%-340.02K | 12.25%-230.24K | 58.26%-114.33K | -1,005.74%-72.04K | 3.42%253.11K | -158.71%-262.39K | -152.07%-273.92K | 104.40%7.95K | -79.36%244.75K | -69.55%446.91K |
| Total composite income | -38.79%332.32M | -39.17%261.82M | -18.12%245.71M | -28.12%105M | 6.91%542.95M | 1.37%430.41M | 3.64%300.09M | -9.67%146.08M | 22.91%507.84M | 51.09%424.61M |
| Total composite income of parent company owners | -39.88%316.25M | -40.05%251.37M | -18.63%238.41M | -28.85%101.52M | 5.62%526M | 0.83%419.3M | 3.48%293.01M | -10.54%142.69M | 25.46%498M | 54.12%415.84M |
| Total composite income of minority owners | -5.13%16.08M | -5.85%10.46M | 2.96%7.3M | 2.47%3.48M | 72.20%16.94M | 26.67%11.11M | 10.76%7.09M | 52.43%3.39M | -39.38%9.84M | -21.85%8.77M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- | -- | -- | ShinWing Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm